China Resources Medical Holdings Company Limited (HKG:1515)
3.840
-0.010 (-0.26%)
Apr 2, 2025, 10:45 AM HKT
HKG:1515 Revenue
In the year 2024, China Resources Medical Holdings Company had annual revenue of 9.85B CNY, down -2.50%. China Resources Medical Holdings Company had revenue of 4.88B in the half year ending December 31, 2024, with 3.90% growth.
Revenue
9.85B CNY
Revenue Growth
-2.50%
P/S Ratio
0.46
Revenue / Employee
493.90K CNY
Employees
19,953
Market Cap
4.99B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.85B | -252.71M | -2.50% |
Dec 31, 2023 | 10.11B | 2.21B | 27.92% |
Dec 31, 2022 | 7.90B | 3.45B | 77.66% |
Dec 31, 2021 | 4.45B | 1.70B | 61.69% |
Dec 31, 2020 | 2.75B | 635.33M | 30.03% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
WuXi Biologics | 19.87B |
JD Health International | 61.89B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Alibaba Health Information Technology | 31.39B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |